Outcomes After Proton Therapy for Treatment of Pediatric High-Risk Neuroblastoma.

Affiliation

Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: [Email]

Abstract

Patients with high-risk neuroblastoma (HR-NBL) require radiation to the primary tumor site and sites of persistent metastatic disease. Proton radiation therapy (PRT) may promote organ sparing, but long-term outcomes have not been studied.

OUR Recent Articles